Edition:
United States

Valeant Pharmaceuticals International Inc (VRX.TO)

VRX.TO on Toronto Stock Exchange

20.96CAD
3:59pm EST
Change (% chg)

$-0.07 (-0.33%)
Prev Close
$21.03
Open
$21.18
Day's High
$21.24
Day's Low
$20.83
Volume
296,256
Avg. Vol
1,422,558
52-wk High
$23.75
52-wk Low
$11.20

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 0.94 December 23 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 2 1 1 1
(3) HOLD 12 13 13 13
(4) UNDERPERFORM 5 5 5 5
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.95 3.00 3.00 3.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 13 2,156.19 2,233.00 2,058.90 2,367.10
Quarter Ending Mar-18 6 2,036.97 2,291.00 1,868.50 2,105.20
Year Ending Dec-17 17 8,714.68 8,794.00 8,582.00 9,360.86
Year Ending Dec-18 20 8,454.58 9,245.00 7,760.00 9,673.06
Earnings (per share)
Quarter Ending Dec-17 13 0.94 1.28 0.83 1.43
Quarter Ending Mar-18 6 0.66 1.02 0.47 1.09
Year Ending Dec-17 15 3.78 4.14 3.61 5.31
Year Ending Dec-18 18 3.51 4.57 2.54 6.14
LT Growth Rate (%) 2 -13.90 -12.90 -14.90 12.10

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 2,157.55 2,219.00 61.45 2.85
Quarter Ending Jun-17 2,218.52 2,233.00 14.48 0.65
Quarter Ending Mar-17 2,183.75 2,109.00 74.75 3.42
Quarter Ending Dec-16 2,338.27 2,403.00 64.73 2.77
Quarter Ending Sep-16 2,494.01 2,479.60 14.41 0.58
Earnings (per share)
Quarter Ending Sep-17 0.89 1.04 0.15 16.60
Quarter Ending Jun-17 0.94 1.03 0.09 9.09
Quarter Ending Mar-17 0.87 0.78 0.09 9.99
Quarter Ending Dec-16 1.20 1.26 0.06 4.59
Quarter Ending Sep-16 1.75 1.55 0.20 11.42

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 2,156.19 2,156.99 2,166.13 2,168.87 2,367.10
Quarter Ending Mar-18 2,036.97 2,036.97 2,056.63 2,101.20 2,105.20
Year Ending Dec-17 8,714.68 8,712.76 8,693.35 8,705.10 9,360.86
Year Ending Dec-18 8,454.58 8,454.58 8,493.23 8,501.62 9,673.06
Earnings (per share)
Quarter Ending Dec-17 0.94 0.93 0.93 0.95 1.43
Quarter Ending Mar-18 0.66 0.66 0.70 0.73 1.09
Year Ending Dec-17 3.78 3.74 3.68 3.69 5.31
Year Ending Dec-18 3.51 3.51 3.52 3.50 6.14

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 6 6
Quarter Ending Mar-18 0 0 1 3
Year Ending Dec-17 0 0 12 5
Year Ending Dec-18 0 0 9 8
Earnings
Quarter Ending Dec-17 0 0 7 6
Quarter Ending Mar-18 0 0 2 2
Year Ending Dec-17 0 0 11 3
Year Ending Dec-18 0 1 6 9